These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5018655)

  • 1. Gut lesions in Fabry's disease without a rash.
    Flynn DM; Lake BD; Boothby CB; Young EP
    Arch Dis Child; 1972 Feb; 47(251):26-33. PubMed ID: 5018655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes.
    Avila JL; Convit J; Velazquez-Avila G
    Br J Dermatol; 1973 Aug; 89(2):149-57. PubMed ID: 4726891
    [No Abstract]   [Full Text] [Related]  

  • 3. Relief of pain of Fabry's disease by diphenylhydantoin.
    Lockman LA; Hunninghake DB; Krivit W; Desnick RJ
    Neurology; 1973 Aug; 23(8):871-5. PubMed ID: 4578349
    [No Abstract]   [Full Text] [Related]  

  • 4. Fabry's disease (ceramide trihexosidase deficiency): diagnostic confirmation by analysis of dental pulp.
    Desnick SJ; Witkop CJ; Krivit W; Thies JK; Desnick RJ
    Arch Oral Biol; 1972 Oct; 17(10):1473-9. PubMed ID: 4507778
    [No Abstract]   [Full Text] [Related]  

  • 5. A kidney transplant patient with Fabry's disease. Unusual features.
    Suros J; Woods JE; Anderson CF; Frohnert PP; Kazmier FJ; Holley KE; Riley FC; DeWeed JH
    Arch Surg; 1973 Feb; 106(2):231-3. PubMed ID: 4568657
    [No Abstract]   [Full Text] [Related]  

  • 6. Anderson-Fabry dyslipidosis.
    Johnson ML
    Proc R Soc Med; 1972 Sep; 65(9):768-70. PubMed ID: 5085061
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.
    Romeo G; Migeon BR
    Science; 1970 Oct; 170(3954):180-1. PubMed ID: 5466114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry's disease: the search for a regulator gene mutation in man.
    Sutton HE; Omenn GS
    Am J Hum Genet; 1972 May; 24(3):343-7. PubMed ID: 5028973
    [No Abstract]   [Full Text] [Related]  

  • 9. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.
    Desnick RJ; Allen KY; Desnick SJ; Raman MK; Bernlohr RW; Krivit W
    J Lab Clin Med; 1973 Feb; 81(2):157-71. PubMed ID: 4683418
    [No Abstract]   [Full Text] [Related]  

  • 10. The biochemical abnormalities in Fabry's disease.
    Kint JA; Dacremont G
    Arch Int Physiol Biochim; 1970 Feb; 78(1):169-71. PubMed ID: 4100872
    [No Abstract]   [Full Text] [Related]  

  • 11. Histochemical and biochemical studies of urinary lipids in metachromatic leukodystrophy and Fabry's disease.
    Pilz H; Müller D; Linke I
    J Lab Clin Med; 1973 Jan; 81(1):7-21. PubMed ID: 4565559
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Pediatr Res; 1973 Aug; 7(8):684-90. PubMed ID: 4732107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry of Fabry's disease].
    Kint JA; Dacremont G
    Arch Belg Dermatol Syphiligr; 1972; 28(3):245-50. PubMed ID: 4664703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cornea verticillata (Fabry syndrome) and glycolipid excretion in the urine].
    Denden A; Pilz H
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1972; 71():126-30. PubMed ID: 4679308
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme transplantation in Fabry's disease.
    Krivit W; Desnick RJ; Bernlohr RW; Wold F; Najarian JS; Simmons RL
    N Engl J Med; 1972 Dec; 287(24):1248-9. PubMed ID: 4563680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fabry's disease].
    Wolfe LS; Mossard JM; Jossot G
    Presse Med (1893); 1970 Nov; 78(47):2051-2. PubMed ID: 5483194
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease.
    Desnick RJ; Simmons RL; Allen KY; Woods JE; Anderson CF; Najarian JS; Krivit W
    Surgery; 1972 Aug; 72(2):203-11. PubMed ID: 4559379
    [No Abstract]   [Full Text] [Related]  

  • 18. Fabry's disease: structural or regulatory mutation?
    Beutler E; Kuhl W
    J Lab Clin Med; 1971 Dec; 78(6):987. PubMed ID: 5131867
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceramide trihexosidosis (fabry's disease) without skin lesions.
    Clarke JT; Knaack J; Crawhall JC; Wolfe LS
    N Engl J Med; 1971 Feb; 284(5):233-5. PubMed ID: 5539345
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.
    Philippart M; Franklin SS; Gordon A
    Ann Intern Med; 1972 Aug; 77(2):195-200. PubMed ID: 4565790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.